Convolutional architectures for virtual screening
Abstract Background A Virtual Screening algorithm has to adapt to the different stages of this process. Early screening needs to ensure that all bioactive compounds are ranked in the first positions despite of the number of false positives, while a second screening round is aimed at increasing the p...
Main Authors: | Isabella Mendolia, Salvatore Contino, Ugo Perricone, Edoardo Ardizzone, Roberto Pirrone |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | BMC Bioinformatics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12859-020-03645-9 |
Similar Items
-
EMBER—Embedding Multiple Molecular Fingerprints for Virtual Screening
by: Isabella Mendolia, et al.
Published: (2022-02-01) -
Maximizing the Performance of Similarity-Based Virtual Screening Methods by Generating Synergy from the Integration of 2D and 3D Approaches
by: Ningning Fan, et al.
Published: (2022-07-01) -
Graph Convolutional Neural Network-Based Virtual Screening of Phytochemicals and In-Silico Docking Studies of Drug Compounds for Hemochromatosis
by: R. Ani, et al.
Published: (2023-01-01) -
Methods for Similarity-based Virtual Screening
by: Thomas Greve Kristensen, et al.
Published: (2013-02-01) -
VSFlow: an open-source ligand-based virtual screening tool
by: Sascha Jung, et al.
Published: (2023-03-01)